Centessa Pharmaceuticals PLC (CNTA): היקף יתרות המזומנים של החברה

סמל תאגידי ולוגו של Centessa Pharmaceuticals PLC (CNTA)

Centessa Pharmaceuticals (CNTA) relies on a decentralized system of laboratories to discover treatments for rare pathologies. The cash balance demonstrates current liquidity, with 0.28 serving as the base parameter value. The scaling model here is binary: successful molecule patenting creates a monopoly. However, a high dependence on clinical trial outcomes renders the commercial prospects hypothetical.

מזומנים ושווי מזומנים של החברה: Centessa Corp (CNTA) עבור 04.07.2022 - 04.07.2026

פילוחי נתונים אנליטיים מרוכזים עבור Centessa Pharmaceuticals plc (CNTA)

- ציטוטים ותחזית אנליסטים:
ניתוח בסיסי של החברה:CNTA centessa.com
פריט של המותג Centessa

For the biopharmaceutical business of Centessa Pharmaceuticals (CNTA), which depends on venture infusions and clinical trial outcomes, liquidity is a critical survival factor. This indicator assesses the volume of highly liquid assets relative to short-term debts, while an analysis of cash and cash equivalents allows investors to determine the company's margin of safety and the risks of inflationary depreciation of unused capital.

מתחרים עיקריים